Correspondence 0001683168-24-006714 from Tianci International, Inc. (CIIT)
Tianci International, Inc.
Date: Sept. 27, 2024 · CIK: 0001557798 · Accession: 0001683168-24-006714
AI Filing Summary & Sentiment
File numbers found in text: 333-280089
Referenced dates: September 19, 2024
Show Raw Text
CORRESP
1
filename1.htm
TIANCI INTERNATIONAL, INC.
Unit B,10/F., Ritz Plaza, No.122 Austin Road, Tsim
Sha Tsui, Kowloon, Hong Kong 999077
September 27, 2024
Mr. Matthew Derby
Office of Technology
Division of Corporate Finance
U.S. Securities and Exchange Commission
Mail Stop 4631
100 F Street, N.E.
Washington, D.C. 20549-4631
Re:
Tianci International, Inc.
Amendment No. 2 to Registration Statement on Form S-1
Filed September 5, 2024
File No. 333-280089
Dear Mr. Derby,
This letter is in response to the letter dated
September 19, 2024, from the staff (the “Staff”) of the Securities and Exchange Commission (the “Commission”)
addressed to Tianci International, Inc. (the “Company,” “we,” and “our”). For ease of reference, we
have recited the Staff’s comments in this response and numbered them accordingly. An amended registration statement on Form S-1
(the “Amendment No. 3”) is being filed to accompany this letter.
Amendment No. 2 to Registration Statement on Form S-1
Risk Factors
While we believe that we and our subsidiaries are currently not
required to obtain permissions or
approvals from Mainland China..., page 34
1.
Please revise to clarify that although
certain risks specific to variable interest entities may not be applicable to you, the issues and risks identified in the Division of
Corporation Finance's November 23, 2020 "Disclosure Considerations for China-Based Issuers" related to China-based operating
companies registering securities with the SEC do still apply, and that the PRC government has oversight authority notwithstanding the
fact that your operations are based in Hong Kong.
1
Response: In response to the
Staff’s comment, the Company respectfully proposes to include the referenced disclosure in the risk factors on pages 34 to
37 of Amendment No. 3, subject to updates and adjustments to be made in connection with any material development of the subject matter
being disclosed.
2.
We note your disclosure that you do not
believe you are required "to obtain any permissions or approvals from the Mainland China authorities, including but not limited
to the China Securities Regulatory Commission (“CSRC”) and the Cyberspace Administration of China (“CAC”), to
operate Roshing’s business or to list our securities on the U.S. exchanges and offer securities, including but not limited to issuing
our common stock to foreign investors; and (ii) we and our subsidiaries have not applied for or been denied of any such permissions or
approvals from the Mainland China authorities." Please tell us whether you relied upon an opinion of counsel with respect to such
conclusions and if not, revise in to state as much and explain why such an opinion was not obtained. Additionally, revise your disclosure
to clarify whether you or your subsidiaries are required to obtain any permissions or approvals from Hong Kong to operate your business
and revise your risk factors as appropriate. To the extent that you are subject to any permission or approval requirements, state affirmatively
whether you have received all requisite permissions or approvals and whether any permissions or approvals have been denied. Please also
describe the consequences to you and your investors if you or your subsidiaries: (i) do not receive or maintain such permissions or approvals,
(ii) inadvertently conclude that such permissions or approvals are not required, or (iii) applicable laws, regulations, or interpretations
change and you are required to obtain such permissions or approvals in the future.
Response: Based on their understanding
of the current PRC laws and regulations, our PRC legal counsel, Jiangsu Junjin Law Firm, have advised that we are not required to obtain
any obtain any permissions or approvals from the Mainland China authorities for consummating this offering, including but not limited
to the CSRC and CAC, to operate Roshing’s business or to list our securities on the U.S. exchanges and offer securities, including
but not limited to issuing our common stock to foreign investors, given that: (i) we are a Nevada company and our only operating subsidiary,
Roshing, is a Hong Kong company and is headquartered in Hong Kong; neither entity has operations in Mainland China; (ii) we do not, directly
or indirectly, own or control any entity or subsidiary in Mainland China, nor are we controlled by any Mainland Chinese company or individual
directly or indirectly; (iii) we currently do not have or intend to set up any subsidiary or enter into any contractual arrangements to
establish a VIE structure with any entity in Mainland China; (iv) only few of Roshing’s customers are Mainland China residents,
which contributed 5.2% and 0.4% of our revenue for the year ended July 31, 2023 and the nine months ended April 30, 2024, respectively;
(v) the majority of our senior managers in charge of the Company’s business operation and management are Hong Kong nationals and
domiciled in Hong Kong; and (vi) all of Roshing’s employees are Hong Kong residents. In addition, our PRC legal counsel, Jiangsu
Junjin Law Firm, has advised that the offering of our securities is neither subject to the mandatory cybersecurity review under the Cybersecurity
Review Measures nor the filing requirements under the Trial Measures.
In response to the Staff’s comments,
we further revised the disclosure on pages iii and 28 of Amendment No. 3 in relation to the permissions or approvals from Hong Kong to
operate our business.
Thank you in advance for your assistance in reviewing
this response and the Amended Registration Statement. Should you have any questions with respect to the above responses, please contact
me or our U.S. legal counsel, Anthony W. Basch.
Sincerely,
/s/ Shufang Gao
Shufang Gao
2